{"id": "1339245373169299464", "creation": 1608135953.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 1, "quote_count": 1}}, "text": "Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted #COVID19 #Vaccine Candidate\n\nVLA2001 leverages the manufacturing platform of Valneva\u2019s licensed Japanese #encephalitis vaccine, IXIARO\u00ae \nhttps://t.co/kojjfZtKNQ", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#ENCEPHALITIS"]}